Programmed Death Receptor-1 Blocking Antibody drugs compared
Compare all 2 Programmed Death Receptor-1 Blocking Antibody drugs side by side, used for conditions such as mesothelioma, malignant, biliary tract neoplasms, urinary bladder neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is keytruda.
2 of 2 drugs in this class carry a pharmaranks safety score, ranging 72–72 out of 100 — computed from FDA recall records, not from reviews.
Top-rated programmed death receptor-1 blocking antibody: 1. Keytruda · 2. Opdivo
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Keytruda | Pembrolizumab | Injectable | Prescription | Mesothelioma, Malignant, Biliary Tract Neoplasms | 72/100 | — |
| Opdivo | Nivolumab | Injectable | Prescription | Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung | 72/100 | — |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best programmed death receptor-1 blocking antibody by condition
Full ranking · 2 drugs
Frequently asked questions
What is the Programmed Death Receptor-1 Blocking Antibody drug class?
Programmed Death Receptor-1 Blocking Antibody is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 2 Programmed Death Receptor-1 Blocking Antibody products, each independently rated.
Are all Programmed Death Receptor-1 Blocking Antibody drugs the same?
No. Programmed Death Receptor-1 Blocking Antibody drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Programmed Death Receptor-1 Blocking Antibody drugs treat?
Per NIH RxClass drug-classification data, Programmed Death Receptor-1 Blocking Antibody drugs are used for conditions including mesothelioma, malignant, biliary tract neoplasms, urinary bladder neoplasms, carcinoma, non-small-cell lung, carcinoma, renal cell, carcinoma, squamous cell.
Which Programmed Death Receptor-1 Blocking Antibody drug is best-rated?
By our independent rating, keytruda currently ranks highest among Programmed Death Receptor-1 Blocking Antibody drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Programmed Death Receptor-1 Blocking Antibody class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.